Savara Inc (SVRA) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 43 days, typically, give or take 17 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Mon, Nov 9, 2026after close 40 10-Q
Q2 FY2026Tue, Aug 11, 2026after close 42 10-Q
Q1 FY2026Tue, May 12, 2026after close 42 10-Q
Q4 FY2025Fri, Mar 13, 2026before open 72 10-K
Q3 FY2025Wed, Nov 12, 2025after close 43 10-Q
Q2 FY2025Wed, Aug 13, 2025before open 44 10-Q
Q1 FY2025Tue, May 13, 2025after close 43 10-Q
Q4 FY2024Thu, Mar 27, 2025before open 86 10-K

What they guided beta

Q2 FY2020 "SAVARA REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE Announces Final Clinical Study Design for IMPALA 2, the Next Phase 3 Study of Molgradex in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Study Expected to Start in Q1 2021 AUSTIN, TX – August 6, 2020 – Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today reported financial results for the second quarter ending June 30, 2020 and provided a business update." exhibit
Q2 FY2020 "“With a final design for IMPALA 2, we are working diligently on study preparations and expect it to start in the first quarter of next year,” said Rob Neville, Chief Executive Officer, Savara." exhibit
Q2 FY2020 "The study is expected to start in the first quarter of 2021." exhibit
Q2 FY2020 "Top line results from AVAIL are still expected in early 2021." exhibit
Q2 FY2020 "The Company anticipates an additional ~$46.0 million in gross proceeds from the second tranche of the December 2019 financing." exhibit
Q1 FY2020 "SAVARA REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE Company Announces Expected Design for IMPALA 2, the Next Phase 3 Study of Molgradex in aPAP AUSTIN, TX – May 7, 2020 – Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today reported financial results for the first quarter ending March 31, 2020 and provided a business update." exhibit
Q1 FY2020 "Top line results are still expected in early 2021." exhibit
Q1 FY2020 "Approximately one hour after the call, a telephone replay will be available and will remain available through May 14, 2020 by dialing (877) 344-7529 from the U.S., (855) 669-9658 from Canada and (412) 317-0088 from elsewhere outside the U.S. and entering the replay access code 10143130." exhibit
Q1 FY2020 "results from AVAIL are still expected in early 2021, that data from the ENCORE study will provide useful information on the safety, and potential efficacy, of Molgradex in people living with cystic fibrosis who have NTM lung infection, our belief that there is sufficient capital to fund planned operations into 2022 under the current operating plan, and our strategy." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/SVRA
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/SVRA

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

SVRA earnings date badge

HTML

<a href="https://veritasdata.dev/company/SVRA/"><img src="https://veritasdata.dev/embed/SVRA.svg" alt="SVRA earnings date" width="240" height="56"></a>

Markdown

[![SVRA earnings date](https://veritasdata.dev/embed/SVRA.svg)](https://veritasdata.dev/company/SVRA/)

Script

<script async src="https://veritasdata.dev/embed/SVRA.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/SVRA"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.